Acitretin Therapy for Pustular Psoriasis
Introduction to Acitretin
- The American Academy of Dermatology recommends acitretin as first-line therapy for generalized pustular psoriasis, due to its rapid response profile, with 84% of patients demonstrating improvement within 3 weeks 1, 2
- Acitretin is preferred over methotrexate for patients with concomitant plaque psoriasis and pustular psoriasis flare, as it demonstrates rapid and impressive responses specifically in pustular psoriasis 1, 2, 3
Rationale for Acitretin as First-Line
- Acitretin shows particularly rapid responses in pustular psoriasis, with improvement seen as early as 3 weeks, compared to its more modest efficacy in plaque psoriasis alone 1, 2
- The American Academy of Dermatology specifically identifies acitretin as first-line therapy for generalized pustular psoriasis, alongside cyclosporine, methotrexate, and infliximab 3
Dosing Strategy for Acitretin
- Standard dosing range is 0.1-1 mg/kg/day (typically 10-50 mg daily in adults) 3
- For pustular flares, response is typically seen within 3 weeks, faster than the 2-3 months required for plaque disease 4, 3
Combination Therapy Considerations
- Acitretin combined with narrowband UVB phototherapy is synergistic and allows dose reduction, which is particularly useful for managing the concomitant plaque component 4, 5, 6
Critical Safety Considerations
- Absolute contraindication in females of childbearing potential without reliable contraception, as acitretin remains stored in the body for up to 3 years when reverse-esterified to etretinate in the presence of alcohol 4, 5
- Most common side effects are mucocutaneous (cheilitis, dry skin, hair loss) and are dose-dependent 4
Alternative Considerations for Severe Cases
- If acitretin fails or disease is rapidly progressive, infliximab 5 mg/kg IV at weeks 0, 2, and 6, then every 8 weeks is recommended for severe pustular psoriasis 5, 3
- Cyclosporine 2-5 mg/kg/day achieves clearance in approximately 4 weeks and is excellent for crisis management 5